BCL2 and gastric cancer: In 2023, Yajie et al. reported that luteolin enhanced cell death rates and reduced cell proliferation by downregulating BCL2 and P-AKT and upregulating cytochrome C, Bax, and caspase-3 in MKN-45 gastric cancer cells (28).